Fundz

Verastem, Inc. reported raising $100 Million in an initial SEC Form D filing, from an offering of $100 Million

PUBLIC · VSTMMar 06, 2020

Amount Raised

$100 Million

$100 Million sold, per SEC Form D (first sale Mar 6, 2020)

Round Type

Venture

NeedhamBiotechnologyHealthcareHealth CareTherapeuticsBiopharma

Quick answer

Verastem Oncology raised $100 Million in a funding round, dated March 6, 2020. Verastem Oncology is based in Needham, Massachusetts, United States.

How much did Verastem Oncology raise?
Verastem Oncology raised $100 Million in a funding round on March 6, 2020.
What does Verastem Oncology do?
Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK..
Where is Verastem Oncology based and how big is it?
Verastem Oncology is based in Needham, Massachusetts, United States. Fundz records about 106 employees.
Who are the decision-makers at Verastem Oncology?
Fundz holds 1 contact at Verastem Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Verastem Oncology that raised within 45 days of this round, from Fundz verified event records.

  • OnKure Therapeutics raised $3.2M (Seed) on April 15, 2020.
  • Phio Pharmaceuticals raised $4.4M on April 14, 2020.
  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • CytoDyn raised $882K (Seed) on March 30, 2020.
  • Olema Oncology, Inc. raised $30M on March 27, 2020.
  • Nurix Therapeutics raised $120M on March 26, 2020.

Who to call at Verastem Oncology, and when

A new round usually means Verastem Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Verastem Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Verastem Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Verastem Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Verastem Oncology

Location

117 Kendrick Street, Suite 500

Needham, Massachusetts, United States

About

Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Verastem Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Verastem Oncology. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Verastem Oncology's next move

See what Strategic adds

Verastem Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.